课题基金 / 基金详情

High-precision dosimetry for ultra-short, high dose-rate irradiation sources

High-precision dosimetry for ultra-short, high dose-rate irradiation sources
超短、高剂量率照射源的高精度剂量测定
批准号:
2892817
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The projects aims at developing and testing new methods for high-precision dosimetry in a novel regime of irradiation of biological samples, with the final aim of establishing a new scheme for radiotherapeutic cancer treatment.Recent work carried out by our group has demonstrated that laser-driven electron and photon beams can access unprecedented regimes of cell response to radiation, with the clear potential to provide significant benefit to patients undergoing radiotherapeutic treatment. In particular, we have demonstrated the possibility of delivering Gy-scale irradiations over ultra-short temporal scales, tuneable from tens of picoseconds down to tens of femtoseconds, resulting in ground-breaking dose rates in the range of 10^11 - 10^14 Gy/s, well beyond the recently discovered FLASH effect. Notably, preliminary work carried out by our group has demonstrated novel features in the response of both healthy and tumour cells, with a significant increase in sparing of healthy tissues and increase in cell killing for tumour cells.In order to continue work in this direction, and precisely establish the effects of ultra-short irradiation on cells, it is mandatory to have precise measurements of the dose delivered to both in-vitro and in-vivo samples. While dosimetric techniques and diagnostics are well established for relatively long irradiation times, detailed work must be done to establish techniques for precise dosimetry at the sub-picosecond level. The group of Prof. Giuseppe Schettino at the National Physics Laboratory (NPL) is a world-leader in dosimetry, and responsible for developing and maintaining the UK primary dosimetry standard which are disseminated to all UK radiotherapy centres. We thus plan to team up with them to study ultra-fast dosimetry that can have deep and far-reaching repercussions in radiobiology and cancer treatment. The successful student will be jointly supervised by myself and Prof. Schettino and, while they will be based for the majority of their time at QUB, they will have placements at NPL. This work at the frontier of both radiation generation and applications will allow the student to gain expertise in a wide range of cutting-edge physical and engineering techniques, such as generating laser-driven ultra-fast radiation sources, characterising them, and developing dosimetric techniques. This work naturally aligns with my research interests, as demonstrated by the sustained funding obtained from research councils on the application of laser-driven radiation and particle sources (£ >10M overall funding secured from research councils in the last 10 years on this topic). This studentship will also complement a research proposal to EPSRC in this area (with NPL as project partner), planned to be submitted in the first half of 2023 in collaboration with the School of Pharmacy and the Centre for Cancer Research & Cell Biology (expected overall value £ >1.5M).The proposed work also naturally aligns with key research priorities within QUB, as demonstrated, for example, by the recent establishment of the Advanced Manufacturing Innovation Centre, and the Institute for Research Excellence in Advanced Clinical Healthcare.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金